Moderna Covid-19 Vaccine
Payments companies reported to CMS as associated with Moderna Covid-19 Vaccine. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Moderna Covid-19 Vaccine, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Moderna Covid-19 Vaccine
These are the largest totals companies reported as associated with Moderna Covid-19 Vaccine. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Sandeep Kukreja | Greenwood, IN | Pulmonary Disease | $148,000.00 |
| Richard Hamill | Houston, TX | Infectious Disease | $136,500.00 |
| Eric Rosenberg | Boston, MA | Infectious Disease | $133,750.00 |
| Sergio Trevino Castillo | Houston, TX | Critical Care Medicine (Internal Medicine) | $132,750.00 |
| Anthony Faugno | Boston, MA | Pulmonary Disease | $131,750.00 |
| Cedric Franklin Rutland | Riverside, CA | Critical Care Medicine (Internal Medicine) | $46,712.20 |
| Janet Englund | Seattle, WA | Pediatric Infectious Diseases | $40,740.00 |
| Nadine Rouphael | Atlanta, GA | Infectious Disease | $29,515.57 |
| Italo Brown | Stanford, CA | Emergency Medicine | $27,914.05 |
| Jeffrey Curtis | Birmingham, AL | Rheumatology | $24,194.23 |
Prescribed Moderna Covid-19 Vaccine?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.